Verona Pharma (VRP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

45.70p
   
  • Change Today:
    -0.30p
  • 52 Week High: 122.50
  • 52 Week Low: 42.30
  • Currency: UK Pounds
  • Shares Issued: 105.33m
  • Volume: 0
  • Market Cap: 48.13m
  • RiskGrade: 208

Verona Pharma Overview

Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe cough

1 Day Chart (21-08-2019)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 0.8  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verona Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 n/a (3.76) (16.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (1,855.00)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (5.97) (750.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (25.20) (23.40) n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (24.13) (18.90) n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verona Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (39.78) (31.52)p n/a n/a n/a n/a 0.0%
31-Dec-20 37.20 (34.08) (21.89)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Verona Pharma Company Announcements

Verona Pharma plc: PDMR Dealing 09-Aug-2019 09:35 GlobeNewswire NA
Verona Pharma plc: Operational Update and F... 06-Aug-2019 07:00 GlobeNewswire NA
Verona Pharma Reports Positive Phase 2 Results w... 05-Aug-2019 07:00 GlobeNewswire NA

Latest Verona Pharma Director Deals

Traded Action Notifier PriceAmountValue
08-Aug-19 Buy David Ebsworth 50.00p 60,000 30,000.00
28-May-19 Buy Piers Morgan 59.00p 33,802 19,943.18

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verona Pharma Market Data

Currency UK Pounds
Share Price 45.70p
Change Today -0.30p
% Change -0.65 %
52 Week High 122.50
52 Week Low 42.30
Volume 0
Shares Issued 105.33m
Market Cap 48.13m
RiskGrade 208

Verona Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.93% above the market average17.93% above the market average17.93% above the market average17.93% above the market average17.93% above the market average
66.10% above the sector average66.10% above the sector average66.10% above the sector average66.10% above the sector average66.10% above the sector average
Price Trend
76.31% below the market average76.31% below the market average76.31% below the market average76.31% below the market average76.31% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Verona Pharma Dividends

No dividends found

Trades for --2019

Time Volume / Share Price
0 @ 0.000p

Verona Pharma Key Personnel

CEO Sven Jan-Anders Karlsson
CFO Piers Morgan

Top of Page